BIO CITY
LIVE

Serial Number

79423791

Owner

UAB "Northway turto valdymas"

Attorney

John Zaccaria

Filing Date

Mar 21, 2025

Add to watchlist:

No watchlists yet
View on USPTO

BIO CITY Trademark

Serial Number: 79423791 • Registration: 8226743

BIO CITY is a trademark filed by UAB "Northway turto valdymas" on March 21, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

UAB "Northway turto valdymas" (17 trademarks)

S.Zukausko g. 21-43

Entity Type: 99

Trademark Details

Filing Date

March 21, 2025

Registration Date

April 28, 2026

Published for Opposition

March 10, 2026

Goods & Services

Medical services; alternative medicine services; in vitro fertilization services; occupational therapy services; human tissue bank services; rental of medical equipment; medical analysis services for diagnostic and treatment of persons provided by medical laboratories

Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; chemical preparations for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19

Scientific and technological services and research and design relating thereto, namely, scientific research and product design in the field of development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; medical and scientific research, namely, conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of pharmaceutical studies; technological consultancy in the technology field of development of manufacturing processes for biotechnology products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 28, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 16, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2026 TROA
REFUSAL PROCESSED BY IB
Oct 24, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 7, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 7, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 24, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 23, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 28, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 28, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 15, 2025 REPR